Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Assets Average (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Assets Average for 12 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 22.35% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 22.35%, and an annual FY2025 reading of $1.5 billion, up 13.85% over the prior year.
  • Assets Average was $1.3 billion for Q4 2025 at Agios Pharmaceuticals, down from $1.4 billion in the prior quarter.
  • Across five years, Assets Average topped out at $2.2 billion in Q2 2021 and bottomed at $811.4 million in Q2 2024.
  • Average Assets Average over 5 years is $1.4 billion, with a median of $1.3 billion recorded in 2022.
  • The sharpest move saw Assets Average soared 145.68% in 2021, then crashed 40.68% in 2022.
  • Year by year, Assets Average stood at $1.5 billion in 2021, then fell by 18.8% to $1.2 billion in 2022, then fell by 19.62% to $972.2 million in 2023, then surged by 77.69% to $1.7 billion in 2024, then dropped by 22.35% to $1.3 billion in 2025.
  • Business Quant data shows Assets Average for AGIO at $1.3 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.5 billion in Q2 2025.